Borregaard Asa (BRRDF) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Borregaard Asa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.482 -- 00:00:07.450 Good morning and welcome to this first quarter 2025 presentation for Beauregard. 00:00:07.450 -- 00:00:12.156 My name is Per Sørli, I'm the President and CEO of the company and I'll be joined this 00:00:12.156 -- 00:00:15.361 morning by Per-Bjarne Lyngstad, our CFO, 00:00:15.361 -- 00:00:20.067 and we'll take you through this agenda. I'll talk about the highlights in the first quarter, 00:00:20.067 -- 00:00:23.656 the market development in the business segments. 00:00:23.656 -- 00:00:29.123 the tariff situation and the Algonor capital race that was 00:00:29.123 -- 00:00:34.010 completed after the end of the quarter and then the outlook for the remainder of the 00:00:34.010 -- 00:00:38.355 year. And Pebjarni will come back and talk about the financial performance. 00:00:38.355 -- 00:00:42.301 And I'd just like to take this opportunity to remind you that if you are watching this 00:00:42.301 -- 00:00:47.808 webcast live, you can put through questions throughout the presentation and we will 00:00:47.808 -- 00:00:53.152 revert at the end of the presentation and talk about these different questions. 00:00:53.255 -- 00:00:55.799 Then first, I'll start with the highlights for the first quarter. 00:00:55.799 -- 00:01:01.108 We ended up delivering an EBITDA of 511 million 00:01:01.108 -- 00:01:05.797 compared to 442 million in the previous same quarter last year. 00:01:05.797 -- 00:01:07.219 This 00:01:07.219 -- 00:01:09.343 was particularly 00:01:09.343 -- 00:01:12.949 driven by the development in BioSolutions, 00:01:12.949 -- 00:01:17.116 where we had an all-time high result for a single quarter. 00:01:17.116 -- 00:01:22.643 And this was particularly explained by the strong sales in agriculture, 00:01:22.643 -- 00:01:25.848 where we have ...